Cover image of the article: The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics

Image Credit:Int J Endocrinol Metab

The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics

Authors

H D Tildesley1,*, J S Wise2, A B Mazanderani2, C A Aydin2, T S Fraser2, E Yu2
1Division of Endocrinology, St. Pauls Hospital and Department of Medicine,University of British Columbia, hught@istar.ca, British Colombia, Canada
2Department of Medicine,University of British Columbia, British Colombia, Canada
*Corresponding Author: Division of Endocrinology, St. Pauls Hospital and Department of Medicine,University of British Columbia, hught@istar.ca, British Colombia, Canada. Email: hught@istar.ca

International Journal of Endocrinology and Metabolism:Vol. 7, issue 2; 51-55
Published online:Apr 30, 2009
Article type:Research Article
Received:Jan 01, 2008
Accepted:May 01, 2009
How to Cite:Tildesley H, Wise J, Mazanderani A, Aydin C, Fraser T, et al. The Effect of the Change in the Definition of Type 2 Diabetes on Patient Demographics. Int J Endocrinol Metab. 2009;7(2):. doi:

Abstract

In 1998 the definition of type 2 diabetes was revised, in particular the fasting plasma glucose (FPG) diagnostic level was lowered from 7.8 mmol/L to 7.0 mmol/L. The purpose of this study was to examine the effects of this change on patient demographics. Materials & Methods: We reviewed data from 1700 type 2 diabetes patients, who attended the St. Paul’s Hospital Diabetes Teaching and Train-ing Centre before (group 1) and after (group 2) the definition change. Demographical data from a baseline and follow-up were analyzed. The frequencies of patients in groups and cohorts <60 years of age and ≥60 years of age were calculated and HbA1c data was analyzed. Results: Compared to Group 1, Group 2 was younger, had a significantly lower mean HbA1c level (7.3% vs 8.1%, p<0.0001), blood pressure (127/78 vs 133/82 mmHg, p<0.05) and cholesterol (5.2 vs 5.5 mmol, p<0.05) and was more often treated with multiple medications (p<0.001). Pa-tients in Group 2 were significantly more likely to meet the target HbA1c level of 7.0% than pa-tients in Group 1 (p<0.0001). It was also found that at baseline, patients ≥60 years old in Group 2 had significantly lower HbA1c values than those <60 years old (p<0.001). Conclusion: Since the change in the definition of type 2 diabetes, a greater frequency of patients presented with lower mean HbA1c values and met target HbA1c levels. Patients ≥60 years old initially presented with lower HbA1c levels than those <60 years old.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

1
Mar
2015
The Effect of Educational Interventions on Glycemic Control in Patients with Type 2 Diabetes Mellitus

The Effect of Educational Interventions on Glycemic Control in Patients with Type 2 Diabetes Mellitus

Mohammad Javad Zibaeenezhad,
Kamran Aghasadeghi,
Fatemeh Zade Bagheri,
Elham Khalesi,
Alireza Moaref,
Mahmood Zamirian
,et al.

Zibaeenezhad MJ, Aghasadeghi K, Zade Bagheri F, Khalesi E, Moaref A, et al. The Effect of Educational Interventions on Glycemic Control in Patients with Type 2 Diabetes Mellitus. Int Cardiovasc Res J. 2017;9(1):e11660. doi:

27
Oct
2024
Factors Associated with Achieving HbA1c Targets in Patients with Type 2 Diabetes

Factors Associated with Achieving HbA1c Targets in Patients with Type 2 Diabetes

Akram Mehrabbeik,
Davood Tofighi,
Saeed Hossein Khalilzadeh,
Reyhaneh Azizi,
Nasim Namiranian,
Farzaneh Azad

Mehrabbeik A, Tofighi D, Khalilzadeh SH, Azizi R, Namiranian N, et al. Factors Associated with Achieving HbA1c Targets in Patients with Type 2 Diabetes. Jundishapur J Chronic Dis Care. 2024;13(4):e147903. doi: https://doi.org/10.5812/jjcdc-147903

1
Oct
2011
Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.

Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.

Z Abdeyazdan,
M Hashemipour,
R Barekatain,
F Kalantary,
M Amini

Abdeyazdan Z, Hashemipour M, Barekatain R, Kalantary F, Amini M. Benefits of Metformin Combined with Insulin in Children with Type 1 Diabetes Mellitus.. Shiraz E-Med J. 2011;12(4):. doi:

17
Oct
2015
Effect of Group Training on Glycemic Control in Patients With Diabetes Type-I

Effect of Group Training on Glycemic Control in Patients With Diabetes Type-I

Marjan Naseri,
Shahnaz Rostami,
Bahman Dashtebozorgi

Naseri M, Rostami S, Dashtebozorgi B. Effect of Group Training on Glycemic Control in Patients With Diabetes Type-I. Jundishapur J Chronic Dis Care. 2015;4(4):e29728. doi: https://doi.org/10.17795/jjcdc-29728

19
Mar
2012
Effect of electronic self-care education and applying continues care on practice in type 2 diabetic patients; a randomized clinical trial

Effect of electronic self-care education and applying continues care on practice in type 2 diabetic patients; a randomized clinical trial

Mariam Khandan,
Esmat Noohi,
Ali Mirzazadeh

Khandan M, Noohi E, Mirzazadeh A. Effect of electronic self-care education and applying continues care on practice in type 2 diabetic patients; a randomized clinical trial. J Kermanshah Univ Med Sci. 2012;15(6):e78896. doi:

More by these authors

H TildesleyPubMedScholar
A MazanderaniPubMedScholar
Share
Cited by
Metrics